Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a254e2079caf4440

Jump to content

AM-2232

From Wikipedia, the free encyclopedia
AM-2232
Legal status
Legal status
Identifiers
  • 5-(3-(1-Naphthoyl)-1H-indol-1-yl)pentanenitrile
CAS Number
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC24H20N2O
Molar mass352.437 g·mol−1
3D model (JSmol)
  • c1ccc2c(c1)cccc2C(=O)c3cn(c4c3cccc4)CCCCC#N
  • InChI=1S/C24H20N2O/c25-15-6-1-7-16-26-17-22(20-12-4-5-14-23(20)26)24(27)21-13-8-10-18-9-2-3-11-19(18)21/h2-5,8-14,17H,1,6-7,16H2 X markN
  • Key:VWVAIBKHFCUSMD-UHFFFAOYSA-N X markN
 X markNcheckY (what is this?)  (verify)

AM-2232 (1-(4-cyanobutyl)-3-(naphthalen-1-oyl)indole) is a drug that acts as a potent but unselective agonist for the cannabinoid receptors, with a Ki of 0.28 nM at CB1 and 1.48 nM at CB2.[1][2]

In the United States, all CB1 receptor agonists of the 3-(1-naphthoyl)indole class such as AM-2232 are Schedule I Controlled Substances.[3]

See also

[edit]

References

[edit]
  1. US patent 7241799, Makriyannis A, Deng H, "Cannabimimetic indole derivatives", granted 2007-07-10
  2. Zagzoog A, Brandt AL, Black T, Kim ED, Burkart R, Patel M, Jin Z, Nikolaeva M, Laprairie RB (May 2021). "Assessment of select synthetic cannabinoid receptor agonist bias and selectivity between the type 1 and type 2 cannabinoid receptor". Scientific Reports. 11 (1) 10611. Bibcode:2021NatSR..1110611Z. doi:10.1038/s41598-021-90167-w. PMC 8134483. PMID 34012003.
  3. 21 U.S.C. § 812: Schedules of controlled substances